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a b s t r a c t
Bluetongue virus (BTV) encodes a single capping protein, VP4, which catalyzes all reactions required
to generate cap1 structures on nascent viral transcripts. Further, structural analysis by X-ray
crystallography indicated each catalytic reaction is arranged as a discrete domain, including a
nucleoside-20-O-methyltransferase (20-O MTase). In this study, we have exploited the structural
information to identify the residues that are important for the catalytic activity of 20-O MTase of
VP4 and their inﬂuence on BTV replication. The effect of these mutations on GMP binding, guanylyl-
transferase (GTase) and methylase activities were analysed by a series of in vitro biochemical assays
using recombinant mutant proteins; subsequently their effects on virus replication were assessed by
introducing the same mutations in replicating viral genome using a reverse genetics system. Our
data showed that single substitution mutations in the catalytic tetrad K-D-K-E were sufﬁcient to
abolish 20-O MTase activity in vitro and to completely abrogate BTV replication in cells; although
these mutants retained the upstream GMP binding, GTase and guanine-N7-methyltransferase
activities. Mutations of the surrounding substrate-binding pocket (predicted to recruit cap0) had
variable effects on in vitro VP4 capping activity. Only triple but not single substitution mutations
of these residues in genome resulted in reduced virus replication kinetics. This is the ﬁrst report
investigating the importance of 20-O MTase function for any member of the Reoviridae and
highlights the signiﬁcance of K-D-K-E tetrad and surrounding residues for the efﬁciency of 20-O
MTase activity and in turn, for virus ﬁtness.
 2015 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Eukaryotic cellular and most viral messenger RNAs (mRNAs) are
modiﬁed at their 50 termini with methylated cap structures, which
promote stability and efﬁcient translation [6,9]. Recent studies on
selected viral methylated caps have revealed that cap structures
may also have a function in cloaking viral messenger from sen-
sors of the host cell innate immune response [5,12,16,17,34,35].
Most viral transcripts are characterized by a cap1 structure
[m7GpppN2m] consisting of a 7-methylguanosine (m7G) linked by
a 50-50 triphosphate bond to the 50 end of the mRNA and the methy-
lation of the 20-OH group of the ribose of the ﬁrst nucleotide. The
cap structure is formed by an orchestrated series of reactions
including the RNA triphosphatase, guanylyltransferase and the
two methylase activities, viz., guanine-N7-methyltransferase
(N7MTase) and nucleoside-20-O-methyltransferase (20-O MTase).
Members of the Reoviridae, such as Bluetongue virus (BTV), encode
speciﬁc viral proteins that are responsible for synthesizing the
cap1 structures at the 50 termini of their RNA transcripts, similar
to most eukaryotic and viral transcripts [23,36]. BTV VP4, a minor
structural protein, alone catalyses the formation of cap1 structure
and therefore possesses multiple catalytic activities [18,23,24]. VP4
forms a complex with the viral polymerase (VP1) and RNA helicase
(VP6) proteins, this polymerase complex (PC) is closely associated
with 10 segments of dsRNA genome [10,21,28] within the double-
capsid virion particle. The PC is located at the 5-fold axis of the
inner capsid layer formed by a single protein, VP3, which in turn
is enclosed by a second layer of VP7 protein. This double-layered
capsid or ‘‘core’’ is further enclosed by an outer capsid, composed
of two proteins, VP2 and VP5, which are involved in virus attach-
ment and entry into the host cells [27]. After cellular entry, the
outer capsid is lost, releasing the core into the cytoplasm [11]
where an active polymerase complex, which remains within the
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unassembled core, synthesizes and extrudes new transcripts
through pores situated at the core 5-fold axis [29]. The 2.5 Å
X-ray crystallographic structure of VP4 showed that the protein
has a unique structural organisation whereby each functional
domain is arranged in sequential fashion to facilitate each catalytic
activity required to form the cap structure of the newly synthe-
sized transcripts [33]. Thus, VP4 offers an ideal model for charac-
terizing each functional domain and determining their relative
contributions to the virus replication cycle.
Recent studies of viral cap structures have revealed the impor-
tance of the 20-O methylation in evading the host innate immune
response to RNA viruses [39]. Modiﬁcation of the catalytic K-D-
K-E tetrad within the domain has been demonstrated to render
the virus replication deﬁcient and mutations of key residues within
the catalytic pocket affect the rate of methylation, which leads to
attenuation [8,13,15]. In this report, we focused on the 20-O
MTase domain of VP4, which although possesses the consensus
fold of the typical class I AdoMet-dependent methyltransferases
and displays some structural similarities with Vaccinia virus
VP39 and Dengue virus NS5 methyltransferase as well as contain-
ing some unique features, the precise roles of which are unclear.
We used structural information to identify key residues within
VP4 20-O MT and veriﬁed their importance employing a series of
biochemical assays and the BTV reverse genetics system. This is
the ﬁrst report to assign function to the putative 20-O MT domain
for the capping enzyme of any member of the Reoviridae.
2. Material and methods
2.1. Virus stocks, cell lines
BSR cells (BHK-21 sub-clone) were maintained in Dulbecco
modiﬁed Eagle medium (DMEM, Sigma Aldrich) supplemented
with 5% (v/v) fetal calf serum (FCS, Invitrogen). The stable
BSR-VP4 (BSR expressing VP4; BSR4) cell line was grown in
DMEM-5% FCS supplemented with 7.5 lg/ml of puromycin
(Sigma Aldrich). Cells and viruses were grown at 35 C in 5% CO2
incubator. BTV-1 wild-type (WT) and mutant virus stocks were
propagated by infecting BSR cells at MOI of 0.5 and harvested when
cytopathic effect (CPE) between 95% and 100% was evident. Titres
of viral stocks were obtained by either plaque assay and/or by
TCID50/ml.
Spodoptera frugiperda (Sf9) cells were grown in either Sf900 III
(Gibco BRL) or InsectExpress (Lonza) media supplemented with
2% (v/v) fetal calf serum and incubated either in suspension or in
monolayer cultures at 28 C. Recombinant Autographa californica
nuclear polyhedrosis virus (AcNPV) that expressed either recombi-
nant BTV-10 VP4 or mutated VP4 was propagated in Sf9 suspen-
sion culture.
2.2. Generation of VP4 cell line
The coding region of S4 (GenBank: FJ969722), VP4, was ampli-
ﬁed and ligated into expression vector pCAG-Puro (pCAG-VP4). BSR
cells were transfected with the pCAG-VP4 plasmid using
Lipofectamine2000 (Invitrogen) as per instruction. After transfec-
tion, cells with integrated copies of the expression vector were
selected by the addition of 7.5 lg/ml of puromycin (Sigma). The
surviving clones were tested for the expression level of VP4 by
western immunoblot and the ability to grow virus.
2.3. Mutagenesis reactions
Site-directed mutagenesis as previously described [37] was
used to introduce site-speciﬁc mutations into the exact copy of
BTV-1 S4 (pUCBTV1T7S4) and coding region of BTV-10 VP4
(pAcYM1VP4; GenBank: D00509). Single mutations were intro-
duced at the speciﬁc residues of the aspartic acid position 265 of
VP4 to either a glutamic acid (D265E) or valine (D265V) and aspar-
agine 311, tyrosine Y334 and arginine 367 residues to an alanine
(A) referred to as N311A, Y334A and R367A. A construct with the
triple mutation, N311A/Y334/R367A (NYR) was also generated.
2.4. Expression and puriﬁcation of wild type and 2-OMT mutant VP4
Baculovirus expressing VP4 with site speciﬁc mutation as
described above were generated as described [38]. Brieﬂy,
pAcYM1VP4 with the mutations and Bacmid: 1629 were transfect-
ed into a monolayer of Sf9 using Genejuice (Novagen) as per
manufacturer protocols. After one round of virus ampliﬁcation,
plaque assay was performed and a number of virus isolates picked.
These plaque puriﬁed viruses were propagated and screened for
VP4 expression. Recombinant protein VP4 was puriﬁed from Sf9
cells infected with AcNPV expressing recombinant VP4 or VP4
mutants as described [33]. 1  108 Sf9 were infected with recombi-
nant baculovirus at MOI  5, cells were harvested at 68 h p.i and
lysed in HNN buffer (50 mM Hepes pH 7.5, 300 mM NaCl, 0.5%
NP40); and lysate was centrifuged and pellet suspended in HN buf-
fer (50 mM Hepes pH 7.5, 1 M NaCl). Supernatants were pooled
and RNA precipitated with the addition of 0.1% polyethylenimine
(PEI). VP4 was puriﬁed via size exclusion on a HiPrepS200 column.
Fractions were collected and VP4 further puriﬁed using a heparin
afﬁnity column. VP4 was eluted from the column using a
250 mM to 2 M NaCl gradient in 25 mM Hepes pH 7.5.
2.5. Synthesis of T7 RNA
Synthesis of capped and uncapped BTV transcripts was as
described previously [3,19]. Brieﬂy, capped T7 transcripts were
synthesized by using a mMESSAGE mMACHINE T7 Ultra Kit
(Ambion), while uncapped T7 transcripts were synthesized by
the RiboMAX Large-Scale RNA Production System T7 (Promega)
according to the manufacturer’s procedure. a32P-labelled RNA
was synthesized using 2.5 mM GTP and 50 lCi a32P-GTP. All RNA
transcripts were dissolved in nuclease-free water and stored at
80 C.
2.6. Recovery and analysis of 20-O MTase mutations in BTV
Mutant andWTBTV-1 viruseswere rescued using a 2-step trans-
fection protocol as previously described [19]. Brieﬂy, monolayers of
either BSR or BSR4 were initially transfected with the plasmid
constructs expressing the sub-core (VP1, VP3, VP4 and VP6) and
non-structural (NS1 and NS2) proteins and after 12–18 h cells were
transfected for a second time with a complete set of T7 derived BTV
mRNAs. DNA andRNA transfectionswere performed in the presence
of Lipofectamine2000 reagent (Invitrogen).
For the growth curves of the mutant or WT viruses, monolayers
of BSR cells were infected at an MOI  0.1. Cells and supernatant
were harvested at different times post-infection and disrupted by
two freeze–thaw cycles; and the total titre was determined by
plaque assay or TCID50/ml.
The dsRNA genome was extracted from virus infected cells as
previously described [32] and analyzed on TBE agarose gel.
Puriﬁed dsRNAs were used as templates to reverse transcribe S4
to generate cDNA using SuperScript III (Invitrogen). S4 was ampli-
ﬁed using speciﬁc primers, using KOD polymerase. PCR products
were sequenced to ensure that the introduced mutations were
stable and that there were no compensatory changes to the S4.
Expression of viral proteins was monitored by western immu-
noblot using speciﬁc polyclonal antibodies that recognize either
VP3 or NS1. Whole cell lysates and fractions were resolved on
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SDS–PAGE gels, and transferred to a nitrocellulose membrane
(0.45 lm, Amersham) by the standard semi-dry transfer protocol.
Each blot was developed with speciﬁc primary and secondary
antibodies.
A Renilla luciferase assay that detects the expression from BTV
S10 (S10-Rluc) RNA reporter plasmid during virus infection was
used to quantify the viral protein synthesis as established [2]. In
brief, BSR monolayer cells in 96 well plates were transfected with
S10-Rluc RNA followed by infection with either BTV or NYR mutant
virus at 12 h post-transfection. Renilla luciferase activity was
quantiﬁed at 12 h post infection using the Renilla Luciferase
Assay System (Promega), according to the manufacturer’s instruc-
tions. Each reaction was performed in triplicate and student t-test
was used to determine signiﬁcance.
2.7. Autoguanylation of VP4
To ensure that the mutations did not interfere with the
structure of the mutant proteins, the stable interaction with VP4
capping enzyme and GMP moiety was undertaken according to
Le Blois et al. [14] with the following modiﬁcation: 2 lg of puriﬁed
recombinant protein and 0.5 lCi/ll of a32P-GTP were used.
Reactions were performed in triplicate and data were analysed
for signiﬁcance using student t-test.
2.8. Guanylyltransferase assays
Guanylyltransferase assays were performed as outlined by
Martinez-Costas et al. [18]. A standard reaction consisted of
50 mM Tris HCl (pH 7.5), 9 mM MgCl2, 6 mM DTT, 10 mM
AdoMet, 6 mM a32P-GTP (50 Ci/mmol), 2 lg of BTV S5 RNA
transcripts as acceptor and 2 lg of puriﬁed VP4. After incubation
at 37 C for 2 h, RNA was extracted and analyzed by MOPS
formaldehyde gel electrophoresis as described [4] followed by
autoradiography. Reactions were performed in triplicate and data
was analysed for signiﬁcance using student t-test.
2.9. Methyltransferase assay
Methyl transfer from Ado[methyl-3H]Met to T7 derived BTV
ssRNAs were used to determine the ability of the methylase activ-
ity of mutant VP4. A standard reaction mixture contained 50 mM
TrisHCl (pH 7.5), 9 mMMgCl2, 2 mMAdo[methyl-3H]Met (87 Ci/m-
mol), 6 mM DTT, 1 lg of uncapped ssRNAs or 0.4 mM Cap analogue
(GpppA, m7GpppG; NEB) and 2 lg puriﬁed protein. After incubation
at 37 C for 2 h, the reaction mixtures were treated with proteinase
K. RNA/cap analogues were puriﬁed by phenol:chloroform
extraction and precipitated with cold ethanol. Cap analogues were
precipitated in 9 vol ice-cold ethanol. The transfer of the 3H-methyl
was determined using PerkinElmer 1450 microbeta. As a negative
control baculovirus infected cytosolic lysate was used, which was
extracted from infected Sf9 cells using HNN buffer as described
for VP4 recombinant proteins, treated with PEI and centrifuged
to remove contaminating RNA and baculovirus particles.
Reactions were performed in triplicate and data were analysed
for signiﬁcance using student t-test.
2.10. In vitro capping assay
To examine the formation of cap structures by recombinant
proteins in vitro, capping assay was performed using the standard
methyltransferase assay as described [4] with the following
modiﬁcations: 5 lg of recombinant protein, 0.5 lCi/ll a32P-GTP
and 1 lg RNA. After incubation for 2 h at 37 C, RNA was puriﬁed
and digested with NucleaseP1 (Sigma) to release the cap structure.
Cap structures were resolved by thin layer chromatography (TLC)
using PEI-cellulose plates (Millipore). Reactions were performed
in triplicate and ImageJ was used to quantify the intensity of the
cap structures generated [30]. Data was analysed for signiﬁcance
using student t-test.
2.11. m7-GTP sepharose interaction with recombinant protein
To determine whether the mutations in 20-O MT domain affect-
ed the binding to cap0, we performed m7-GTP pull-down assay.
Puriﬁed recombinant protein was incubated with m7-GTP sephar-
ose at 4 C for at least 4 h. Samples were centrifuged at 500g for
5 min, unbound fraction removed and washed the beads 3 times
with binding buffer (50 mM TrisHCl pH 7.5, 300 mM NaCl, 0.5%
NP40) supplemented with cold GTP to remove non-speciﬁc inter-
actions. Interacting proteins were eluted from the beads by the
addition of SDS–PAGE sample buffer. Samples were resolved and
analyzed by western immunoblot using VP4 polyclonal antibody.
3. Results
3.1. Expression and functional activities of recombinant VP4 mutant
proteins targeting 20-OMT domain
The 2.5 Å crystal structure of the 74 kDa BTV VP4 suggested that
residues 175 to 377 encode a distinct 20-O MT domain segregated
from the other domains and is responsible for methylation of cap0
structure (Fig. 1). Currently, there is no direct evidence available
that this domain is indeed responsible for 20-O MTase activity,
although it includes putative signature catalytic residues, K178-
D265-K306-E335, similar to the other catalytic motif of class I
AdoMet-dependent methyltransferases (Fig. 1; [33]). Based on pre-
vious VP4 ligand binding data [33] and studies on other viruses, we
hypothesized that aspartic acid 265 (D265) is critical for 20-O
MTase activity. We focused on D265 rather than other catalytic
residues as it is in proximate distance with the residues that bind
S-adenosyl-L-homocysteine (SAH) and guanosine of the cap struc-
ture (Fig. 1). In addition, we identiﬁed a cluster of surface exposed
amino acids N311, Y334 and R367 that are in close proximity to the
guanosine in the ligand binding pocket (Fig. 1; [33]). In particular,
Y334 and possibly N311 are predicted to interact with guanine of
the cap0 [33], while R367 is believed to be responsible for recruit-
ing the N7 cap (Fig. 1; [33]). Thus, these residues could be impor-
tant in assisting the 20-O MTase catalytic activity either through
direct interaction with cap0 or by recruiting it within the catalytic
domain. Site-speciﬁc mutations into the coding region of VP4 were
introduced to generate D265E and D265V to either conserve the
charge or change the polarity of the residue. Similarly, residues
N311, Y334 and R367 were mutated to an alanine either singly
or in combination (NYR). The mutated constructs were expressed
using the baculovirus expression system and each protein was
puriﬁed in soluble fraction indicating that the speciﬁc mutations,
in particular, the surface exposed substitutions, have little or no
effect on solubility (data not shown).
Since VP4 catalyzes all reactions of the cap methylation path-
way in a sequential manner, it was necessary to ensure that muta-
tions of any of the residues did not affect the upstream reactions.
Firstly, we analysed the GMP-VP4 complex formation by the
mutant proteins to ensure the process of autoguanylation was
retained. The mutant proteins (D265E and D265V, N311A, Y334A,
R367A and NYR) and VP4 WT were incubated with a32P-GTP for
30 min and products were analyzed by SDS–PAGE, followed by
autoradiography. All recombinant mutant proteins exhibited
formation of VP4-a32P-GMP intermediate complexes, albeit at
variable amounts (Fig. 2A). There was some reduction (4–20%)
in GMP binding by all mutant proteins in comparison to WT VP4
140 M.E. Stewart, P. Roy / FEBS Open Bio 5 (2015) 138–146
but this was not signiﬁcant. A number of residues within VP4 have
been shown to bind guanosine and phosphates including residues
Y334 and D265 [33]. Thus the reduction in autoguanylation
observed by mutant proteins was likely due to disruption of speci-
ﬁc guanosine interaction (Fig. 2A). No complexes were detected in
the control reactions either with baculovirus lysate or in absence of
any VP4, conﬁrming the speciﬁc interaction between VP4 and GMP
(Fig. 2A). Overall, the mutations did not result in a signiﬁcant
decrease in autoguanylation consistent with the unaltered struc-
tural integrity of each mutant VP4.
Since mutant proteins formed a stable covalent bond with GMP,
we investigated whether the bound GMP could be transferred from
VP4 to the 50 end of the ssRNAs to form the ‘cap’ structure i.e., the
guanylyltransferase activity. All mutant recombinant proteins and
WT VP4 were therefore incubated with unlabelled and uncapped
T7 generated RNAs of one of the BTV segments (S5) in the presence
of a32P-GTP for 2 h. The puriﬁed ssRNAs were analyzed by a dena-
tured gel and a32P-labelled RNAs were detected. All recombinant
mutant proteins as well as control WT protein were able to gener-
ate a32P radio-labelled ssRNAs conﬁrming that the GMP moiety
(a32P-GMP) was transferred to the 50 ppG-RNA of the BTV ssRNA
(Fig. 2B). N311A mutant protein catalyzed the capping of the
ssRNA as efﬁciently as WT VP4. While mutations of the residues
(Y334A, R367A and NYR) that are exposed at the VP4 surface and
were predicted to interact with cap0, and D265 mutants were less
efﬁcient at transferring the GMP to the ssRNA (Fig. 2B). The reduc-
tion in guanylyltransferase activity (5–20%) observed for these
mutant proteins was the same as that observed for the GMP bind-
ing activity. Reaction without VP4 did not generate any labelled
ssRNAs (Fig. 2B). These results indicate that the function of the
GTase domain was not signiﬁcantly affected by the introduction
of these mutations and structural integrity was maintained.
3.2. Methylation of cap by VP4 mutant proteins
Since the mutations were speciﬁcally introduced into the 20-O
MT domain, to deﬁne its functional role, we examined if
these mutations affected the catalytic ability of the VP4 to methy-
late the penultimate nucleotide of the 50 end of cap0. To investigate
the effect of mutations at the putative catalytic tetrad on 20-O
Fig. 1. Tertiary structure of VP4 with S-adenosyl-L-homocysteine (SAH; orange) and 7 N-methyl-8-hydroguanosine-50-diphosphate (m7G; navy blue) ligands (adapted from
Sutton et al., [35]). Superimposed structures of BTV VP4 PDB: 2JHP and 2JH8. (A) The catalytic K-D-K-E site is highlighted in a pink dash box within the ribbon structure of
VP4. (B) Magniﬁcation of catalytic pocket and key residues postulated to be involved in catalytic activity (dark red) and recruiting cap0 (pink) within 2-OMTase are indicated.
Fig. 2. Autoguanylation and guanylyltransferase activities of VP4 20-O MT mutant proteins. (A) a32P-GMP-VP4 complex formation by autoguanylation analyzed by SDS–
PAGE, visualized and quantiﬁed. The signal for each protein relative to WT VP4 (set at 100%). (B) Transfer of a32P-GMP moiety from VP4 to acceptors ssRNAs. Uncapped BTV
S5 ssRNAs was incubated with VP4 mutant proteins in the presence of a32P-GTP, resolved on a MOPS-formaldehyde gel, visualised and quantiﬁed. As above the signal for the
mutant proteins is relative to WT VP4 (set at 100%). (A and B) Data was normalised to the amount of protein in each assay are from triplicate experiments, error bars are
standard deviations; ⁄p < 0.05.
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MTase activity, recombinant D265E, D265V and WT VP4 proteins
were incubated with cap0 analogue (m7GpppG) in the presence of
Ado[methyl-3H]Met for 2 h. The cap analogue was puriﬁed to
remove the unincorporated Ado[methyl-3H]Met and transfer of
methyl-3H was determined. While the WT VP4 efﬁciently
methylated the cap0 analogue, the two mutant proteins failed to
methylate the cap0 analogue (Fig. 3A). The values observed for
D265E and D265V were equivalent to the two negative controls,
with no signiﬁcant differences observed between the two mutants
(D265E, p < 0.1; D265V, p < 0.73; Fig. 3A). Our results demonstrat-
ed that only recombinant WT VP4 protein was able to methylate
m7GpppG while the mutation of D265 to either E or V abolished
this catalytic function. To ensure that the catalytic activities of
the 20-O MT and N7MT domains of VP4 act independently, we
performed the same reaction as above but substituted the cap0
analogue (m7GpppG) with an unmethylated cap analogue
(GpppA); the later is not a natural substrate for VP4 as the 50
penultimate base for BTV transcript is a guanosine. Both D265
mutant and WT VP4 proteins were able to methylate the GpppA
cap analogue to generate m7GpppA when compared with the cell
lysate, indicating that the mutant proteins had retained the N7MT
activity, albeit at reduced levels (Fig. 3B). This set of results demon-
strated that the D265 residue within the K-D-K-E tetrad is essential
for VP4 catalytic activity. Further, these results may indicate that
the 20-O MT and N7MT catalytic domains act independently.
When the same in vitro assay was performed using cap0 ana-
logue (m7GpppG) with cap0 binding pocket mutant proteins, each
mutant still showed some 20-O MTase activity. In particular, the
single mutation of the residues Y334 or R367 did not affect the
transfer of the methyl group to cap0 analogue (m7GpppG)
(Fig. 4A), while mutation at the residues N311 and NYR mutant
protein had 2-fold reduction in the incorporation of
Ado[methyl-3H]Met (Fig. 4A). As these mutations were designed
to disrupt the recruitment of the BTV transcripts with cap0 from
the N7-MT domain, we used an uncapped BTV ssRNAs acceptor,
instead of cap0 analogue, as it is representative of the reaction
by VP4 that occurs within the core particle. Mutant and WT VP4
proteins, uncapped BTV ssRNAs and Ado[methyl-3H]Met were
incubated together, BTV ssRNAs were puriﬁed and amount of
methyl-3H transferred to an equivalent amount of ssRNAs was
determined. All mutant proteins showed signiﬁcant reduction in
transferring methyl-3H to the uncapped ssRNAs (Fig. 4B). The data
demonstrated that the mutation of the putative cap binding pocket
retained 2-O MTase activity but the efﬁciency of formation of cap1
structure on ssRNAs acceptors, however, was hampered. These
results supported that these residues are involved in the in vitro
catalytic activity of VP4.
To understand further the effect of mutant NYR on cap methy-
lation, we investigated the kinetics of the same reaction. NYR
mutant and WT VP4 proteins were incubated with T7 derived
ssRNAs in the presence of Ado[methyl-3H]Met as described above
and samples were analysed at 30 min intervals. The cap methyla-
tion reaction to generate cap1 structure at the 50 termini of
ssRNAs was severely delayed by the NYR mutant; 3H-methyl
labelled ssRNAs could be barely detected at 150 min time point
(Fig. 4C). In contrast, transfer of the methyl-3H to the ssRNAs by
WT VP4 at the same time point was at least a 100-fold higher than
that of the mutant protein. (Fig. 4C). 20-O MTase activity was
severely hampered by the substitution of NYR residues to alanine,
as was also true when the m7GpppG cap0 analogue was used as a
substrate (data not shown).
Overall, our data identiﬁes a key role of residue D265 within the
catalytic tetrad to maintain 20-O MT function of VP4. Further, it
highlights that the triple residues (N311, Y334 and R367) mutated
in combination perturb the efﬁciency of catalytic activity of VP4 for
cap1 formation at the 50 termini of the transcripts.
3.3. Mutation of N311 is associated with decreased binding to m7 of
cap0 structure
The decrease in methylation activity prompted us to further
investigate if the reduced activity was due to perturbed interaction
between VP4 and cap0 structure as hypothesized. To this end a
qualitative pull-down assay was used to examine whether the
mutant VP4 proteins were able to interact with m7 of the cap1.
Each protein was incubated with m7-GTP linked to sepharose
beads and washed in a solution containing excess GTP to reduce
background and speciﬁc interaction with the guanosine. The bound
VP4 was visualized by western analysis using anti-VP4 antibody.
Recombinant mutant proteins Y334A and R367 and VP4 WT pro-
tein were pulled-down by m7-GTP demonstrating that each pro-
tein interacted with the m7-GTP (Fig. 5). In contrast, the N311A
and NYR mutants failed to interact with the m7-GTP as neither
were detected in the pulled-down fraction (Fig. 5). The results indi-
cate that N311 amino acid most likely interacts with the methyl
group of the cap0 within the catalytic domain of 20-O MTase.
3.4. 20-O MTase activity is essential for virus replication
To investigate the importance of 20-O MT activity on virus repli-
cation we examined the D265 mutants in the context of virus repli-
cation. To this end the D265E and D265V mutations were
introduced into the S4 and BTV reverse genetics (RG) system used
[3,19] to recover mutant viruses in mammalian BSR cells, WT VP4
plasmid was excluded from the ﬁrst transfection and replaced with
mutant T7 S4 ssRNA. In spite of several attempts, it was not possi-
ble to recover any virus, with either mutants of D265 in normal
BSR cells, indicating that these substitution mutations were not
tolerated and lethal for virus growth in mammalian cells (Fig. 6A).
In order to determine if these two mutant viruses could be res-
cued when a native VP4 was provided in trans, a stable cell line
(BSR4) constitutively expressing WT VP4 was generated. The
BSR4 cells were transfected with each mutant S4 transcripts
together with 9 BTV-1 transcripts and monitored for CPE and pla-
que formation. Both mutant viruses were successfully rescued in
the complementary cell line with plaque morphology similar to
that of the WT BTV virus (Fig. 6A). The disruption of the catalytic
site could be compensated by the normal VP4 supplied in trans.
Further, viruses grown in the complementary BSR4 cells were used
to infect both normal BSR and BSR4 in parallel, at an MOI  1 and
viral structural and non-structural proteins (VP3 and NS1)
Fig. 3. Methylation of cap analogues by K-D-K-E mutant proteins. (A) 20-O MTase
activity. (B) N7MTase activity. (A and B) Mutant VP4 proteins and Ado[methyl-
3H]Met was incubated with either cap0 analogue (m7GpppG) or unmethylated cap
(GpppA) analogue as described. The addition of 3H-methyl to cap0 or cap analogue
was detected by microbeta counter. Control negative reactions are indicated. Data
are from triplicate experiments, error bars are standard deviations; ⁄p < 0.05.
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synthesis were examined. The expression of BTV proteins was
detected in both cell lines at 24 h post infection indicating that
the mutant viruses were able to infect and express the viral pro-
teins in both cell lines (Fig. 6B). Progeny mutant viruses grown in
normal BSR cells failed to replicate further (data not shown). The
dsRNA genome of the mutant viruses were extracted from BSR4,
infected cells, but not from normal cells, were puriﬁed and had a
typical BTV genome proﬁle indicating that there were no abnormal
segments and genome replication was occurring (Fig. 6C).
3.5. Triple mutation within 20-O MTase inﬂuence virus growth
The mutation of non-catalytic residues either singly or in com-
bination indirectly affected 20-O MTase activity in vitro, therefore,
we investigated the biological signiﬁcance of these residues on
BTV replication. The same mutations as described were introduced
at each position (N311, Y334 or R367) either singly or in combina-
tion (NYR) into the S4 genomic clone and reverse genetics system
used to recover each mutant virus. Unlike the mutants of the cat-
alytic residue (D265E or D265V), all other mutant viruses were
recovered from normal BSR cells (Fig. 7A). The plaque morphology
of the viruses with Y334A and R367A mutations were comparable
to WT virus, while N311A and NYR mutation viruses exhibited
smaller plaque sizes (Fig. 6A). Development of plaques was slowest
in the virus with a triple mutation (NYR) taking up to 5 days p.i. to
yield pinhead sized plaques (data not shown), signiﬁcantly smaller
than the normal plaque size of WT at 3 days p.i. (Fig. 7A). Although,
there was a distinct difference in the plaque size, sequence analysis
of the genomic S4 segment of the mutant viruses after 10 passages
demonstrated that the mutant viruses were stable.
The differences in the development and size of the plaques of
the mutant viruses were also reﬂected in the titres and growth
kinetics monitored over 96 h (Fig. 7B). The Y334A mutant virus fol-
lowed a growth pattern similar to that of the WT virus; similar
titres were observed at all time-points measured indicating no
apparent effect on virus replication. However, the other three
mutant viruses, N311A, R367A and NYR, had titres lower than
the WT virus (1–3.5log10), the R367A mutant virus titres were con-
sistently 1log10 lower thanWT at each time point. For the ﬁrst 24 h
p.i., the growth of the N311A followed a pattern similar to both the
WT and Y334A mutant viruses in BSR cells. However, after 24 h p.i.,
the growth curve of the N311A mutant virus plateaued with titres
between 1log10 to 1.5 log10 lower than WT. The growth of the NYR
mutant virus within the ﬁrst 24 h p.i. was slower than all three sin-
gle mutant viruses and the WT and as observed with the N311A
virus, growth curve plateaued after 24 h p.i. The NYR mutant virus
consistently had titres of 2.5–3.5log10 lower than WT (Fig. 7B).
As NYR mutant virus replication showed the most drastic effect
on replication in comparison to the WT virus, we examined the
viral protein synthesis at different time points. At 48 h p.i., both
structural (e.g., VP3) and non-structural proteins (e.g., NS1) were
detected in cell infected with the mutant virus although at levels
lower than that of WT (Fig. 7C), consistent with the low virus titres.
In order to quantify the difference in protein expression between
the NYR mutant andWT viruses, a more sensitive Renilla luciferase
assay was undertaken [2]. Cells were transfected with an S10-RLuc,
an ssRNA that expresses Renilla luciferase under the regulation of
BTV NS1, followed by infection with NYR mutant or WT BTV.
Renilla luciferase production was quantiﬁed 12 h p.i (Fig. 7D). In
contrast to NYR mutant virus and control, Renilla luciferase
activity was 4-fold higher in the WT BTV infected cells
(Fig. 7D). These results conﬁrmed that the mutations affecting
the growth of the viruses also perturb the viral protein production
during early infection.
Fig. 4. Methylase activity of cap0 binding mutant proteins. (A) 20-O MTase activity. Cap0 analogue (m7GpppG) was incubated with VP4 mutant proteins and Ado[methyl-
3H]Met as described. The addition of 3H-methyl to cap0 analogue was detected by microbeta counter. Data are from triplicate experiments, error bars are standard
deviations; ⁄p < 0.05. (B) Cap methylation of ssRNAs was incubated with recombinant protein and Ado[methyl-3H]Met; RNA was puriﬁed and analyzed for methyl-3H transfer
by microbeta counter. This assay does not discriminate methylase activities of the N7MTase and 20-O MTase domains of VP4. (C) Kinetics of methylation of ssRNAs by NYR (d)
and WT (e) mutant VP4 proteins. ssRNAs was incubated with the recombinant proteins as described and samples taken at 30 min intervals. Data are from triplicate
experiments, error bars are standard deviations; ⁄p < 0.05.
Fig. 5. Effect of mutations on interaction with m7-GTPand the kinetics of 20-O
MTase activity. Detection of VP4 bound to m7GTP-sepharose by western immuno-
blot analysis using a monospeciﬁc polyclonal aVP4 (upper panel). Amount of
puriﬁed VP4 protein as an input is shown (lower panel).
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4. Discussion
BTV VP4, unlike many other viral capping enzymes, possesses
all the catalytic activities required for the generation of methylated
cap structure at the 50 terminus of BTV transcripts. Crystal struc-
ture of VP4 revealed that the protein consisted of four indepen-
dent, discrete functional domains each with a discrete role in the
capping pathway. The putative 20-O MTase domain which is
Fig. 6. Rescue of BTV-1 with site speciﬁc mutations in the 2-OMTase domain of VP4. (A) Plaque morphology at 3 days p.i. of K-D-K-E catalytic mutant viruses (D265E and
D265V) grown in either normal BSR or BSR4 cells. (B) Protein analysis by immunoblot of BTV proteins in infected cells at different time point’s p.i. as indicated. VP3 and NS1
were detected using monospeciﬁc polyclonal antibodies; aVP3 or aNS1 respectively. As a loading control, cellular protein b-actin was detected using aActin antibody
(Sigma). (C) dsRNA genome proﬁle of BTV WT, D265E and D265V mutant viruses grown in complementary BS4 cells.
Fig. 7. Growth properties of recovered mutant BTV-1 viruses with site speciﬁc mutations in the 2-OMTase domain of VP4 in normal BSR cells. (A) Plaque morphology at day 3
and 5 p.i. note that plaque development of NYR mutant virus is delayed until 5 days p.i. plaques were visualized with 0.5% crystal violet. (B) Growth kinetics at different time
points over 96 h. Cells were infected with an MOI of 0.1, viruses were harvested and titres determined by TCID50/ml. The growth proﬁle of each virus is indicated; WT (d),
N311A (s), Y334A (h), R367A (N) and NYR (j). (C) Western immunoblot analysis of BTV proteins (VP3 and NS1) at different time p.i. as indicated. VP3 and NS1 were detected
using polyclonal antibodies aVP3 or aNS1, respectively. As a loading control cellular protein b-actin was detected using aActin (Sigma). (D) Expression of S10-Ruc reporter in
response to BTV infection. Cells were transfected with S10-RNA Renilla reporter RNA, infected with either WT or NYR mutant virus, and Renilla luciferase activity measured at
12 h p.i. ⁄Indicates p < 0.05. Reactions were performed in triplicate.
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responsible for the last catalytic reaction of the cap structure, is
attached via a small linker to the other upstream enzymatic
domains including kinase-like, GT and N7-MT that are responsible
for the upstream reactions of pathway. The highly ordered struc-
ture of VP4 highlighted the importance of synthesizing BTV cap
in a sequential manner. To date no functions have been assigned
to any domain of VP4 and the purpose of this report was to obtain
structure-based biochemical evidence for function focussing main-
ly on the 20-O MTase domain by generating a series of targeted
mutations in the recombinant VP4 as well as in the replicating viral
genome.
The mutations in VP4 20-O MTase domain were designed to tar-
get a key catalytic residue and the residues of the cap0 binding
pocket (Fig. 1) that ideally would not inﬂuence the functions of
the other domains. We initially ensured that the substitution
mutations did not adversely hamper the upstream activity of the
other domains and that the domains acted discretely as predicted.
Since autoguanylation and guanylyltransferase reactions are the
basis for all the downstream catalytic activities of VP4 and essen-
tial for initiating the cap methylation pathway, any interruption of
these reactions would prevent the methylation of the transcripts.
When examined in vitro, the mutations in either the catalytic K-
D-K-E tetrad or surrounding residues were still capable of the
upstream catalytic activities including autoguanylation and guany-
lyltransferase highlighting that the activities of these domains are
most likely to be separate from 20-O MT domain. The slight
decrease in the formation of a stable GMP-VP4 complex exhibited
by the single substitution mutation D265 (K-D-K-E) and Y334 (one
of the three residues in cap binding pocket) supported the crystal
ligand binding data, indicating that the substitutions might have
disrupted the interaction with the penultimate 50 guanosine of
the transcript and G0 base of GTP, respectively. Unlike the single
site speciﬁc mutations introduced into rotavirus VP3 that abol-
ished autoguanylation [22], single and triple amino acid substitu-
tion within BTV VP4 did not disrupt other proposed sites of GMP
interaction, suggesting that the structural integrity of the protein
was maintained.
Although the mutation of the D265 did not affect autoguanyla-
tion and guanylyltransferase activity in vitro, the 20-OMTase activ-
ity was completely abolished. It was not surprising, as similar
results have been reported for mutation of the aspartic residue
for many class I AdoMet-dependent methyltransferases
[1,13,26,34]. The D265 residue of VP4 is closely aligned to the resi-
dues bound to AdoMet and the guanosine of Cap0 [33] highlighting
its importance for 20-O MTase catalytic activity. Previous bio-
chemical analysis indicated that methylation of the cap structure
by VP4 followed a conventional pathway with N7MTase preceding
the 20-O MTase activity [23]. As the D265 mutation had abolished
the 20-O MTase activity of VP4, it was of interest to investigate
whether the activity of the N7MT and 20-O MT domains were inde-
pendent, unlike what has been reported for ﬂaviviruses [8]. Our
results demonstrated that the D265 mutant proteins were able to
methylate the cap analogue GpppA (a cap structure that does not
occur naturally for BTV), indicating that the N7MT activity had
been retained albeit to lower levels than the WT. Although, further
validation is required, these results would suggest that as hypothe-
sized, N7MT activity was located in a discrete domain, separated
from the 20-O MTase domain.
The importance of this residue in the catalytic tetrad of 20-O
MTase for virus replication was clear when the same mutations
were introduced into the replicating virus. The fact that VP4
D265 mutations abolishes the 20O-MTase activity and were lethal
for virus replication, highlights the biological signiﬁcance of this
residue and the critical nature of 20O-MT for BTV replication. The
formation of cap1 structure through the use of viral 20-O MTase
has been demonstrated to be an essential activity for virus replica-
tion for a number of RNA viruses (VSV, Coronavirus, Dengue, WNV,
JEV; [1,5,7,16]). Such a drastic effect on virus replication due to a
single mutation within the 20-O MTase catalytic domain is not
always observed for all viruses, most often only a reduction in
the virus titres and growth kinetics has been observed [15,20].
There are a number of plausible explanations for the failure to
recover BTV mutants in normal cells. It is currently not possible
to test these hypotheses as the VP4 used to complement function
is assembled into the virions. Unlike the capping enzyme for other
viruses which are non-structural (Dengue, alphaviruses,
coronaviruses) VP4 is a minor structural protein and therefore
the WT VP4 present in the complementary cell line is assembled
into the core particle and cannot be dissociated from the virus.
It is clear that 20-O MTase must recruit and position the newly
synthesized cap0 within the catalytic site for the reaction to occur.
We postulated that a disruption of the residues forming the sub-
strate/cap binding pocket would have an effect on the overall func-
tion of the domain. The ligand interactions studies with VP4 [33]
enabled us to identify three residues that may be involved in bind-
ing the cap0 and/or its recruitment. The substitution of the three
residues (N311, Y334, and R367) in the cap binding pocket,
whether singly or in combination, retained the upstream cap
methylation activities (autoguanylation and guanylyltransferase).
Initially, the N311 and Y334 residues were hypothesized to inter-
act with the guanosine residue while R367 is in proximity of the
m7 of cap0. Our autoguanylation and m7-GTP data suggest that
residue R367 probably interacts with the guanosine residue while
N311 interacts with the m7 as also corroborated with the ligand
binding data from crystallisation studies [33].
In comparison to the D265 mutation, these mutant proteins
exhibited the in vitro 20-O MTase activity albeit at reduced level
in comparison to WT VP4. Interestingly, mutagenesis of the sur-
rounding three residues, the putative substrate binding pocket,
had less drastic effect on virus replication. Only the introduction
of the triple mutation resulted in signiﬁcant effect on in vivo virus
replication. The diminished 20-O MTase activity could have a 2-fold
effect on the virus ﬁtness; ﬁrstly decreased protein production
would result in less virus progeny, and secondly the virus’ inability
to control the innate immune response. Previously, we and others
have shown BTV proteins regulate the innate immune response
during infection [25,31], lower viral protein production and growth
may correspond with a more robust immune response early in
infection.
We have shown that structure-based rationally-designed muta-
tions within the VP4 20-O MTase domain did not affect the function
of the other domains of the protein suggesting that each domain is
likely to be functionally segregated. Our genetic and biochemical
data demonstrates that mutations in VP4 have a deleterious effect
on the kinetics of cap1 synthesis and virus replication. Thus, not
only is the preservation of the catalytic tetrad important, the posi-
tioning the cap0 structure in the catalytic domain is critical for
in vitro activity. The results presented here have contributed our
understanding of the role of VP4 in BTV replication and increased
our knowledge in mRNA cap methylation for the members of the
Reoviridae.
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